CLINICAL_TRIALS
research
· 2025-04-11
Clinical Trial Update: Understanding and Treating Suicidal Ideation With Ketamine [Phase 2, Phase 3]
Summary
A clinical trial update indicates ketamine is being studied in Phase 2 and Phase 3 trials for suicidal ideation and major depressive disorder, currently recruit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Royal's Institute of Mental Health Research | Conditions: Suicidal Ideation, Major Depressive Disorder (MDD) | Phase 2, Phase 3 | Status: RECRUITING